申请人:U.S. Philips Corporation
公开号:US04192893A1
公开(公告)日:1980-03-11
The novel compounds of formula I and salts thereof have a very powerful anti-depressive activity which for a considerable part, and in some substances even entirely, is based on serotonine potentiation. Moncamino oxidase inhibition does not contribute to the anti-depressive effect. The substances are little toxic and substantially free from side effects. The compounds can be synthesized and processed to compositions according to known methods.
公式I和其盐的新化合物具有非常强大的抗抑郁活性,其中相当大一部分,甚至在某些物质中完全基于血清素增强作用。单胺氧化酶抑制对抗抑郁效果没有贡献。这些物质毒性小,基本没有副作用。这些化合物可以按照已知方法合成和加工成组成物。